Biocidal products must be phased off the NI market The active substance/product type combinations listed below are due to expire under the EU Biocidal Products Regulation (EU BPR) on the following dates. This affects NI: Methyl-benzimidazol-2-ylcarbamate (carbendazim) (CAS 10605-21-7 EC 234-232-0) in product types 7 and 10
31 January 2025 Powdered corn cob (CAS n/a EC n/a) in product type 14
31 January 2025 Thiamethoxam (CAS 153719-23-4 EC 428-650-4) in product type 18
31 January 2025 Synthetic amorphous silicon dioxide (nano) (CAS 112926-00-8 EC 231-545-4) in product type 18
31 October 2025 Once the approvals expire, the active substances will no longer be able to be used in biocidal products of the relevant product types in NI. In addition articles treated with such products will no longer be able to be placed on the market in NI. Â If you hold an affected EU BPR product authorisation or Control of Pesticides Regulations (COPR) product approval, we will contact you about cancelling or revoking your authorisation or approval. You will have an opportunity to submit comments or additional information and we will take account of these when finalising our decision. Â If you are aware of any disproportionate negative impacts that are likely to arise from the expiry of any of the active substance/product type combinations listed above, please contact us. Submit a notification by the deadline to keep active substances in the EU Review Programme The European Chemicals Agency (ECHA) has published open invitations to provide an opportunity for a person, company or task force/consortium to notify an intention to take up or take over the role of participant in the EU Review Programme for the following active substance/product type combinations. Â This affects NI. Anyone wishing to support one of the active substance/product type combinations listed below in the EU will need to submit a notification to ECHA by the following deadlines: Chlorine dioxide generated from tetrachlorodecaoxide complex (TCDO) by acidification (CAS n/a EC n/a) in product types 2 and 4
20 October 2024 Tetrahydro-1,3,4,6-tetrakis(hydroxymethyl)imidazo[4,5-d]imidazole-2,5 (1H,3H)-dione (TMAD) (CAS n/a EC n/a) in product type 12
31 January 2025 If a notification to take over the role of participant is not received, these active substance/product type combinations will be subject to an EU non-approval decision. Â This means the active substances will no longer be able to be used in biocidal products of the relevant product types in NI. In addition articles treated with such products will no longer be able to be placed on the market in NI. HSE will provide separate updates on these where relevant. Â If you are aware of any disproportionate negative impacts that are likely to arise from the non-approval of any of the active substance/product type combinations listed above, please contact us. | 